Phase III Multi-Center, Double-Blind, Comparative Study of Effexor XR for the Treatment of Depression

Wyeth is now a wholly owned subsidiary of Pfizer73 个研究点分布在 1 个国家目标入组 590 人开始时间: 2004年6月1日最近更新: 2007年5月24日

适应症

试验速览

阶段: 3 期
状态: 已完成
发起方
入组人数: 590
试验地点: 73
主要终点: Response rate of HAM-D17 (Hamilton Rating Scale for Depression) at the final-on-therapy.

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

Study Evaluating Effexor XR for Major Depression.

研究设计

研究类型: Interventional
分配方式: Non Randomized
干预模型: Parallel
主要目的: Treatment
盲法: Double

入排标准

年龄范围: 20 Years 至 64 Years（Adult）
性别: All
接受健康志愿者: 否

入选标准

•Patients diagnosed with major depression based on DSM-IV-TR
•Patients having minimal total score of 18 on the HAM-D17 and minimal score of 2 on the item of "depressed mood" at the baseline.

排除标准

•Patients with schizophrenia or any other psychotic disorder
•Patients with history or presence of bipolar disorder

结局指标

主要结局

Response rate of HAM-D17 (Hamilton Rating Scale for Depression) at the final-on-therapy.

次要结局

Difference of total score of HAM-D17 between baseline and final-on-therapy.
Remission rate of HAM-D17 at the final-on-therapy.

研究者

发起方

Wyeth is now a wholly owned subsidiary of Pfizer

申办方类型

Industry

研究点 (73)

Loading locations...

相似试验

已完成

3 期

Study Evaluating Effexor XR in Elderly Patients With Major Depression.Depression

NCT00225485Wyeth is now a wholly owned subsidiary of Pfizer100

已完成

3 期

Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.Depression

NCT00225524Wyeth is now a wholly owned subsidiary of Pfizer150

招募中

3 期

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and FibrosisNASH With FibrosisMASH With Fibrosis

NCT06215716Akero Therapeutics, Inc1,650

招募中

3 期

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASHNASH - Nonalcoholic SteatohepatitisMASH - Metabolic Dysfunction-Associated Steatohepatitis

NCT06528314Akero Therapeutics, Inc2,150

Unknown

3 期

Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer TreatmentCarcinomas

NCT00935675Gustave Roussy, Cancer Campus, Grand Paris100